Higher doses of aspirin were associated with greater bleeding risks but not better ischemia outcomes, according to an analysis of data on 2,851 people treated with percutaneous coronary intervention for ST-segment elevation myocardial infarction. The study in the Journal of the American College of Cardiology: Cardiovascular Interventions examined data from the HORIZONS-AMI trial.
Study: Less is better when it comes to aspirin after heart procedure
SmartBrief Job Listings for Health Care
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan